P71.9
Transitory neonatal disorder of calcium and magnesium metabolism, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Transitory neonatal disorder of calcium and magnesium metabolism (ICD-10 code P71.9) is a temporary condition affecting newborns, characterized by abnormal levels of calcium and magnesium in the blood. These minerals are vital for various bodily functions, including muscle activity, nerve transmission, and bone development. Usually, this condition resolves without lasting effects, but early recognition and management are important to prevent complications.
Causes & Symptoms
Clinical Causes: Immature organs, such as the kidneys, which may not effectively regulate mineral levels in newborns Inadequate intake of calcium and magnesium through maternal milk or formula Premature birth, resulting in underdeveloped metabolic regulation systems Maternal health issues, including deficiencies or metabolic imbalances that affect fetal mineral stores Certain genetic or metabolic disorders affecting mineral processing
Key Symptoms: Muscle weakness or tremors Irritability or abnormal movements Poor feeding or refusal to eat Lethargy or excessive sleepiness Seizures in severe cases Unusual irritability or jitteriness
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to measure levels of calcium and magnesium in the newborn’s blood. Additional tests may include urine analysis and assessments of kidney function. Healthcare providers also monitor clinical signs and symptoms to support diagnosis. Timing is critical, as early detection can lead to more effective management and recovery.
Treatment Protocols: Treatment strategies focus on restoring normal mineral balance and may include:
Clinical Advice & FAQs
Billing Guidance
Is P71.9 a billable ICD-10 code?
Yes, P71.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P71.9?
Clinical documentation must specify the nature of Transitory neonatal disorder of calcium and magnesium metabolism, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
